Drug therapy versus electroconvulsive therapy for refractory schizophrenia: Report of a case with 14 years of follow-up

Wei Min Dang; Tian Hang Zhou; Mo Zhou; Han Zhi Luo; Wen Sheng Huang; Qing Mei Kong; Lian Sheng Gao; Hong Ping Yao; Jin Pang

doi:10.2190/PM.45.3.d

Drug therapy versus electroconvulsive therapy for refractory schizophrenia: Report of a case with 14 years of follow-up

Wei Min Dang, Tian Hang Zhou, Mo Zhou, Han Zhi Luo, Wen Sheng Huang, Qing Mei Kong, Lian Sheng Gao, Hong Ping Yao, Jin Pang

Peking University

Research output: Contribution to journal › Article › peer-review

2 Scopus citations

Abstract

The long-term efficacy and safety of electroconvulsive therapy (ECT) for refractory schizophrenia is rarely reported. We report the case of a 38-year-old female patient with refractory schizophrenia who was treated with ECT for 14 years (from 24 years of age). Case records of clinical treatment and laboratory tests are described and analyzed. During the first 11 years, the patient was treated with ECT as an adjunct to antipsychotic drugs, but the effectiveness was unstable. For the remaining 3 years she was treated with antipsychotic drugs as an adjunct to ECT and her condition stabilized as she gradually recovered social function. We summarize the clinical characteristics, therapy regimen, long-term effectiveness, and safety of this interesting case.

Original language	English
Pages (from-to)	245-260
Number of pages	16
Journal	International Journal of Psychiatry in Medicine
Volume	45
Issue number	3
DOIs	https://doi.org/10.2190/PM.45.3.d
State	Published - Jan 1 2013
Externally published	Yes

Keywords

efficacy
long-term ECT
refractory schizophrenia
safety

UN SDGs

This output contributes to the following UN Sustainable Development Goals (SDGs)

Access to Document

10.2190/PM.45.3.d

Cite this

@article{d03aa2ea842f43d9937bdb02be9d7d25,

title = "Drug therapy versus electroconvulsive therapy for refractory schizophrenia: Report of a case with 14 years of follow-up",

abstract = "The long-term efficacy and safety of electroconvulsive therapy (ECT) for refractory schizophrenia is rarely reported. We report the case of a 38-year-old female patient with refractory schizophrenia who was treated with ECT for 14 years (from 24 years of age). Case records of clinical treatment and laboratory tests are described and analyzed. During the first 11 years, the patient was treated with ECT as an adjunct to antipsychotic drugs, but the effectiveness was unstable. For the remaining 3 years she was treated with antipsychotic drugs as an adjunct to ECT and her condition stabilized as she gradually recovered social function. We summarize the clinical characteristics, therapy regimen, long-term effectiveness, and safety of this interesting case.",

keywords = "efficacy, long-term ECT, refractory schizophrenia, safety",

author = "Dang, {Wei Min} and Zhou, {Tian Hang} and Mo Zhou and Luo, {Han Zhi} and Huang, {Wen Sheng} and Kong, {Qing Mei} and Gao, {Lian Sheng} and Yao, {Hong Ping} and Jin Pang",

year = "2013",

month = jan,

day = "1",

doi = "10.2190/PM.45.3.d",

language = "English",

volume = "45",

pages = "245--260",

journal = "International Journal of Psychiatry in Medicine",

issn = "0091-2174",

publisher = "SAGE Publications Inc.",

number = "3",

}

TY - JOUR

T1 - Drug therapy versus electroconvulsive therapy for refractory schizophrenia

T2 - Report of a case with 14 years of follow-up

AU - Dang, Wei Min

AU - Zhou, Tian Hang

AU - Zhou, Mo

AU - Luo, Han Zhi

AU - Huang, Wen Sheng

AU - Kong, Qing Mei

AU - Gao, Lian Sheng

AU - Yao, Hong Ping

AU - Pang, Jin

PY - 2013/1/1

Y1 - 2013/1/1

N2 - The long-term efficacy and safety of electroconvulsive therapy (ECT) for refractory schizophrenia is rarely reported. We report the case of a 38-year-old female patient with refractory schizophrenia who was treated with ECT for 14 years (from 24 years of age). Case records of clinical treatment and laboratory tests are described and analyzed. During the first 11 years, the patient was treated with ECT as an adjunct to antipsychotic drugs, but the effectiveness was unstable. For the remaining 3 years she was treated with antipsychotic drugs as an adjunct to ECT and her condition stabilized as she gradually recovered social function. We summarize the clinical characteristics, therapy regimen, long-term effectiveness, and safety of this interesting case.

AB - The long-term efficacy and safety of electroconvulsive therapy (ECT) for refractory schizophrenia is rarely reported. We report the case of a 38-year-old female patient with refractory schizophrenia who was treated with ECT for 14 years (from 24 years of age). Case records of clinical treatment and laboratory tests are described and analyzed. During the first 11 years, the patient was treated with ECT as an adjunct to antipsychotic drugs, but the effectiveness was unstable. For the remaining 3 years she was treated with antipsychotic drugs as an adjunct to ECT and her condition stabilized as she gradually recovered social function. We summarize the clinical characteristics, therapy regimen, long-term effectiveness, and safety of this interesting case.

KW - efficacy

KW - long-term ECT

KW - refractory schizophrenia

KW - safety

UR - http://www.scopus.com/inward/record.url?scp=84881150236&partnerID=8YFLogxK

U2 - 10.2190/PM.45.3.d

DO - 10.2190/PM.45.3.d

M3 - Article

C2 - 24066408

AN - SCOPUS:84881150236

SN - 0091-2174

VL - 45

SP - 245

EP - 260

JO - International Journal of Psychiatry in Medicine

JF - International Journal of Psychiatry in Medicine

IS - 3

ER -

Drug therapy versus electroconvulsive therapy for refractory schizophrenia: Report of a case with 14 years of follow-up

Abstract

Keywords

UN SDGs

Access to Document

Other files and links

Fingerprint

Cite this